300497 Jiangxi Fushine Pharmaceutical
- 7.77
- -0.20-2.51%
Jiangxi Fushine Pharmaceutical News
Fuxiang Pharmaceutical: Announcement on the Withdrawal of the Application for the Company to Issue Stock Application Documents to Specific Targets through Simplified Procedures
Jiangxi Fushine Pharmaceutical: Announcement Regarding the Completion of Vice General Manager's Shareholding
Jiangxi Fushine Pharmaceutical: Announcement Regarding the Completion of Vice General Manager's Shareholding
Jiangxi Fushine Pharmaceutical: Announcement on the progress of the plan for the controlling shareholders, actual controllers, chairman, vice chairman and senior management of the company to increase their shareholding in the company and more than half of the time
Jiangxi Fushine Pharmaceutical: Announcement on the completion of the increase in holdings of the controlling shareholders, actual controllers and chairman of the company
Jiangxi Fushine Pharmaceutical: Summary report of Changjiang Securities Underwriting and Sponsorship Co., Ltd. on the issuance of shares by Jiangxi Fuxiang Pharmaceutical Co., Ltd. to specific targets and listing on GEM
Jiangxi Fushine Pharmaceutical: Notice on extending the validity period of the resolution to issue shares to specific targets through simplified procedures and the validity period of related authorizations
Jiangxi Fushine Pharmaceutical: Announcement on the 2023 Profit Distribution Plan
Fuxiang Pharmaceutical: Announcement on the revised instructions for the plan to issue shares to specific targets using a simplified procedure
Fuxiang Pharmaceutical: Prompt Notice on Disclosure of the 2023 Stock Issuance Plan (Revised Draft) Using Simplified Procedures to Specific Targets
Fuxiang Pharmaceutical: Notice on Issuing Shares to Specific Targets in 2023 with Simplified Procedures, Diluted Immediate Returns, and Measures to Fill Returns and Related Entities\' Commitments (Revised Draft)
Fuxiang Pharmaceutical: Verification and Analysis Report on the 2023 Stock Issuance Plan to Specific Targets Using Simple Procedures (Revised Draft)
Fuxiang Pharmaceutical: 2023 Stock Issuance Plan to Specific Targets with Simple Procedures (Revised Draft)
Fuxiang Pharmaceutical: Feasibility Analysis Report on the Use of Funds Raised by Issuing Shares to Specific Targets with Simple Procedures in 2023 (Revised Draft)
Fuxiang Pharmaceutical: Announcement on the Company's Authorization to Issue Shares to Specific Targets through Simple Procedures
Fuxiang Pharmaceutical: Closing Notice on the Completion of the Use of Funds Raised for Some Stock Issuance Projects to Specific Targets
Fuxiang Pharmaceutical: Announcement on the completion of the company's vice chairman's holdings increase
Fuxiang Pharmaceutical: Announcement on the completion of the company's deputy general manager's holdings increase
Fuxiang Pharmaceutical: Announcement on the completion of the increase in the company\'s financial director\'s holdings
Fuxiang Pharmaceutical: Announcement on supplementary pledges for some shares of the company\'s controlling shareholder
Analysis
Price Target
No Data
